New Era of ADME and Beyond (NE-ADME 2026)
June 10, 2026 at MODERNA
325 Binney St., Cambridge, MA 02142
![]() |
Plenary LectureAmit Kalgutkar, PhDSenior Research Fellow, Rare Diseases & Antivirals Therapeutic Areas DMPK Portfolio Lead at Pfizer Title TBA |
||||
![]() |
Nikhil Pillai, PhDSenior Principal Scientist, Sanofi Machine Learning-Enabled Prediction of Human PK for Early Drug Discovery |
![]() |
Bjorn HaldSenior Scientist II - Drug Metabolism, Novo Nordisk peptide discovery and development for the ADME/DMPK perspective/NN approach to functionalize peptides into drugs - Title TBA |
||
![]() |
Xiaohua Zhu, PhDSenior Director, DMPK at Nimbus Therapeutics Optimizing ADME/DMPK Strategy to Accelerate Drug Discovery |
![]() |
Sophie Tourdot, PhDAssociate Research Fellow, Immunogenicity Sciences Lead, Pfizer predictive modeling ; In-silico - title TBA |
||
![]() |
Vaibhav Maheshwari, PhDAssociate Director, EMD Serono PROTAC's compound selection and translation strategy based on simple mathematical model |
![]() |
Stefan Steyn, PhDResearch Fellow, Pfizer PROTAC ADME challenges including PPB based on their recent publication - the plasma protein binding aspects of PROTACs - Title TBA |
||
















